Anthony L. Rostain, MD, MS
Professor of Psychiatry and Pediatrics
Medical Director, Adult Developmental Disorders Section
Anthony L. Rostain, MD is a Professor of Psychiatry and Pediatrics at the University of Pennsylvania. He is currently the Director of Education for the Department of Psychiatry at the University of Pennsylvania and oversees both medical student and resident education in psychiatry. Dr. Rostain received a B.A. from Yale University in 1972, graduating Cum Laude in Philosophy and Psychology. He then went on to receive a Masters in Science Education from Southern Connecticut State College in 1974. He received his MD in 1980 from New York University School of Medicine and a Masters in Sociology in 1985 from the University of Pennsylvania. He was a Robert Wood Johnson Foundation Clinical Scholar from 1983-85 at the University of Pennsylvania after which he completed residency in adult Psychiatry at the Hospital of the University of Pennsylvania and in child and adolescent psychiatry at the Philadelphia Child Guidance Clinic. He was in charge of psychiatric services at The Children's Hospital of Philadelphia from 1988-91 and was a founder of the region's first program for children with Attention Deficit Hyperactivity Disorder in 1988.
Dr. Rostain's clinical focus is "lifespan developmental neuropsychiatry" which includes patients of all ages with Attention-Deficit / Hyperactivity Disorder, Asperger's Syndrome and High Functioning Autism, Tourette Syndrome, Learning Disabilities (verbal and nonverbal) and related social learning disorders. He treats patients at The Children's Hospital of Philadelphia and the University Of Pennsylvania Department of Psychiatry. Dr. Rostain is the Director of the Adult Development Disorders Unit at the University of Pennsylvania which includes the Adult ADHD Treatment and Research Program and the Adult Social Learning Disorders Program. He is also Co-Director of The Children's Hospital of Philadelphia's Pediatric Neuropsychiatry Program.
Dr. Rostain's research interests have focused on improving clinical outcomes for patients with neuropsychiatric disorders of all ages, and in creating effective service systems for these patients and their families. He recently completed a study of combined medication and cognitive-behavioral therapy (CBT) for adults with ADHD. He is currently involved in studies of differential therapeutic efficacy of medication and CBT, of neuropsychological functioning in ADHD patients (using behavioral measures and neuroimaging techniques), of developmental processes in young adults with ADHD, of predictors of treatment response, and of co-morbid conditions such as anxiety and substance abuse. He is also conducting research on clinical assessment and pharmacologic treatment of patients with Asperger's Syndrome, High Functioning Autism and other Social Learning Disorders.
Back to Top